{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:34:47Z","timestamp":1792445687334,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jad.2018.10.357","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T17:34:19Z","timestamp":1540748059000},"page":"488-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Tachyphylaxis in major depressive disorder: A review of the current state of research"],"prefix":"10.1016","volume":"245","author":[{"given":"Gustavo","family":"Kinrys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra K.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4046-3205","authenticated-orcid":false,"given":"Vincent D.","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George I.","family":"Papakostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mischoulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Nierenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2018.10.357_bib0001","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/nyas.12718","article-title":"Ketamine as a promising prototype for a new generation of rapid-acting antidepressants","volume":"1344","author":"Abdallah","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2018.10.357_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JGP.0b013e31813546f2","article-title":"Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression","volume":"16","author":"Alexopoulos","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0003","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2005.06.011","article-title":"MAOI efficacy and safety in advanced stage treatment-resistant depression\u2014a retrospective study","volume":"89","author":"Amsterdam","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.10.357_bib0004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0b013e318166c4e6","article-title":"Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study","volume":"28","author":"Amsterdam","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2018.10.357_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000226611","article-title":"Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder","volume":"59","author":"Amsterdam","year":"2009","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2018.10.357_bib0006","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/JCP.0000000000000894","article-title":"Maintenance ketamine therapy for treatment-resistant depression","volume":"38","author":"Archer","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2018.10.357_bib0007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/009127006900900106","article-title":"Tachyphylaxis in epidural analgesia: I. Augmentation and decay of local anesthesia","volume":"9","author":"Bromage","year":"1969","journal-title":"J. Clin. Pharmacol. J. New Drugs"},{"key":"10.1016\/j.jad.2018.10.357_bib0008","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.brs.2014.07.040","article-title":"The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT","volume":"7","author":"Brunelin","year":"2014","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2018.10.357_bib0009","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamapsychiatry.2016.3644","article-title":"Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis","volume":"74","author":"Brunoni","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1176\/ps.48.6.835","article-title":"Psychiatrists' responses to failure of maintenance therapy with antidepressants","volume":"48","author":"Byrne","year":"1997","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2018.10.357_bib0011","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4088\/JCP.v59n0602","article-title":"Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments","volume":"59","author":"Byrne","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0012","first-page":"272","article-title":"Poor response to fluoxetine: underlying depression, serotonergic overstimulation, or a\" therapeutic window\"?","volume":"53","author":"Cain","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0013","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1755-5949.2009.00102.x","article-title":"RESEARCH: validation of the massachusetts general hospital Antidepressant Treatment History Questionnaire (ATRQ)","volume":"16","author":"Chandler","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jad.2018.10.357_bib0014","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/00000542-196809000-00027","article-title":"The role of pH in the development of tachyphylaxis to local anesthetic agents","volume":"29","author":"Cohen","year":"1968","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jad.2018.10.357_bib0015","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1176\/ajp.147.12.1627","article-title":"Outcome of patients with chronic affective disorder: a five-year follow-up","volume":"147","author":"Coryell","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0016","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4088\/JCP.v60n0302","article-title":"The Texas Medication Algorithm Project: report of the Texas consensus conference panel on medication treatment of major depressive disorder","volume":"60","author":"Crismon","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0017","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4088\/JCP.v68n0617","article-title":"Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials","volume":"68","author":"Crossley","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0018","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HRP.0b013e3182a75cc7","article-title":"Massachusetts General Hospital SAFER criteria for clinical trials and research","volume":"21","author":"Desseilles","year":"2013","journal-title":"Harvard Rev. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0019","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.4088\/JCP.11ac07225","article-title":"ASCP Corner: assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire","volume":"72","author":"Desseilles","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/ajp.124.8S.55","article-title":"Effects of imipramine on individuals varying in level of depression","volume":"124","author":"Di Mascio","year":"1968","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00148581-200507040-00001","article-title":"Continuation and maintenance therapy of early-onset major depressive disorder","volume":"7","author":"Emslie","year":"2005","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.jad.2018.10.357_bib0022","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.euroneuro.2011.06.006","article-title":"Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study","volume":"22","author":"Fabrazzo","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2018.10.357_bib0023","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000288880","article-title":"Do antidepressant and antianxiety drugs increase chronicity in affective disorders?","volume":"61","author":"Fava","year":"1994","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2018.10.357_bib0024","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jpsychires.2005.06.005","article-title":"Management of depression relapse: re-initiation of duloxetine treatment or dose increase","volume":"40","author":"Fava","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.10.357_bib0026","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brs.2017.09.010","article-title":"Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)","volume":"11","author":"Fava","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2018.10.357_bib0027","first-page":"52","article-title":"Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose","volume":"56","author":"Fava","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0028","first-page":"36","article-title":"Possible therapeutic window for serotonin reuptake inhibitors","volume":"55","author":"Fichtner","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0029","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0269881118760660","article-title":"Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial","volume":"32","author":"Galvez","year":"2018","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.jad.2018.10.357_bib0030","first-page":"419","article-title":"Updates on transcranial magnetic stimulation therapy for major depressive disorder","volume":"41","author":"Garnaat","year":"2018","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.jad.2018.10.357_bib0031","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0165-0327(89)90038-4","article-title":"Relapse of depressed patients after effective continuation therapy","volume":"17","author":"Georgotas","year":"1989","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.10.357_bib0032","series-title":"Manic-depressive illness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"issue":"Suppl","key":"10.1016\/j.jad.2018.10.357_bib0033","first-page":"61","article-title":"Guidelines for the long-term treatment of depression","volume":"55","author":"Hirschfeld","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0034","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40473-016-0075-4","article-title":"Current trends in identifying rapidly acting treatments for depression","volume":"3","author":"Ionescu","year":"2016","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"10.1016\/j.jad.2018.10.357_bib0035","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.4088\/JCP.13m08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0036","first-page":"129","article-title":"Tachyphylaxis\/tolerance to antidepressive medications: a review","volume":"48","author":"Katz","year":"2011","journal-title":"ISR J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.jad.2018.10.357_bib0037","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1001\/jama.1983.03340240025024","article-title":"Predictors of relapse in major depressive disorder","volume":"250","author":"Keller","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2018.10.357_bib0038","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4088\/JCP.v68n0812","article-title":"The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: outcomes from the 2-year and combined maintenance phases","volume":"68","author":"Keller","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.jad.2018.10.357_bib0039","first-page":"29","article-title":"Management of recurrent depression","volume":"54","author":"Kupfer","year":"1993","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jad.2018.10.357_bib0041","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.genhosppsych.2015.01.003","article-title":"Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis","volume":"37","author":"Lee","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0042","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/0022-006X.75.2.267","article-title":"Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression","volume":"75","author":"Leykin","year":"2007","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2018.10.357_bib0043","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0306-9877(84)90018-5","article-title":"Antidepressant tachyphylaxis","volume":"15","author":"Lieb","year":"1984","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jad.2018.10.357_bib0044","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00004714-198312000-00007","article-title":"Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition","volume":"3","author":"Mann","year":"1983","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2018.10.357_bib0045","first-page":"485","article-title":"Clinical usefulness of therapeutic neuromodulation for major depression: a systematic meta-review of recent meta-analyses","volume":"41","author":"McGirr","year":"2018","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.jad.2018.10.357_bib0046","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jad.2016.08.029","article-title":"Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants","volume":"208","author":"Mischoulon","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.10.357_bib0047","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/0972-2327.91935","article-title":"Repetitive transcranial magnetic stimulation in psychiatry","volume":"14","author":"Mishra","year":"2011","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.jad.2018.10.357_bib0048","series-title":"Treatment of Depression-Newer Pharmacotherapies: Evidence Report-Technology Assessment","author":"Mulrow","year":"2000"},{"key":"10.1016\/j.jad.2018.10.357_bib0049","first-page":"13","article-title":"Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy","volume":"64","author":"Nierenberg","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0050","first-page":"1","article-title":"Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Ontario","year":"2016","journal-title":"Ontario Health Technol. Assess. Ser."},{"key":"10.1016\/j.jad.2018.10.357_bib0051","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":"Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis","volume":"68","author":"Papakostas","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0052","doi-asserted-by":"crossref","first-page":"175","DOI":"10.9740\/mhc.2018.07.175","article-title":"Kappa opioid receptor antagonism: are opioids the answer for treatment resistant depression?","volume":"8","author":"Peckham","year":"2018","journal-title":"Mental Health Clin."},{"key":"10.1016\/j.jad.2018.10.357_bib0053","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.0001-690X.2003.00168.x","article-title":"Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20\u00a0mg\/day","volume":"108","author":"Perlis","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2018.10.357_bib0054","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.nmd.0000110280.19284.47","article-title":"Assessing past treatment history: test-retest reliability of the treatment response to antidepressant questionnaire","volume":"192","author":"Posternak","year":"2004","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2018.10.357_bib0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4088\/JCP.v66n0605","article-title":"Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study","volume":"66","author":"Posternak","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0056","article-title":"Further evidence that a placebo response to antidepressants can be identified","author":"Quitkin","year":"1993","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.jad.2018.10.357_bib0057","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.psychres.2017.09.009","article-title":"Maintenance repetitive transcranial magnetic stimulation (rTMS) for relapse prevention in with depression: a review","volume":"262","author":"Rachid","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2018.10.357_bib0058","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301113","article-title":"Effects of risperidone augmentation in patients with treatment-resistant depression: results of open-label treatment followed by double-blind continuation","volume":"31","author":"Rapaport","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.10.357_bib0059","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1176\/ajp.153.11.1418","article-title":"High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression","volume":"153","author":"Reynolds","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.biopsych.2013.10.024","article-title":"Rapid mood-elevating effects of low field magnetic stimulation in depression","volume":"76","author":"Rohan","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0061","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.comppsych.2008.03.002","article-title":"The Rothschild scale for antidepressant tachyphylaxis: reliability and validity","volume":"49","author":"Rothschild","year":"2008","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0062","first-page":"5","article-title":"Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study","volume":"42","author":"Rothschild","year":"2009","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2018.10.357_bib0063","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study","volume":"168","author":"Rush","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0064","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0893-133X(01)00271-8","article-title":"Vagus nerve stimulation (VNS\u2122) for treatment-resistant depression: efficacy, side effects, and predictors of outcome","volume":"25","author":"Sackeim","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.10.357_bib0066","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000063643","article-title":"Treatment approaches to major depressive disorder relapse","volume":"71","author":"Schmidt","year":"2002","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2018.10.357_bib0067","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4088\/JCP.v66n0818g","article-title":"Reply to\" It looks like\" Bradyphylaxis\" to Me.\"","volume":"66","author":"Solomon","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0068","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1176\/appi.ajp.157.2.229","article-title":"Multiple recurrences of major depressive disorder","volume":"157","author":"Solomon","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0069","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4088\/JCP.v66n0302","article-title":"Tachyphylaxis in unipolar major depressive disorder","volume":"66","author":"Solomon","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03004526","article-title":"Continuous epidural analgesia: experience with mechanical injection devices","volume":"17","author":"Spoerel","year":"1970","journal-title":"Can. Anaesth. Soc. J."},{"key":"10.1016\/j.jad.2018.10.357_bib0071","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1345\/aph.1D172","article-title":"Meta-analysis of placebo rates in major depressive disorder trials","volume":"37","author":"Stolk","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jad.2018.10.357_bib0072","first-page":"32","article-title":"Natural course and placebo response in short-term, placebo-controlled studies in major depression: a meta-analysis of published and non-published studies","volume":"38","author":"Storosum","year":"2004","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl 13","key":"10.1016\/j.jad.2018.10.357_bib0073","first-page":"23","article-title":"When at first you don't succeed: Sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0074","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00023210-199504040-00004","article-title":"Relapse and recurrence of depression","volume":"4","author":"Thase","year":"1995","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2018.10.357_bib0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4088\/JCP.v69n0211","article-title":"Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression","volume":"69","author":"Trivedi","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.357_bib0076","first-page":"93","article-title":"Recurrent vital depressions. A follow-up study of 56 female and 28 male patients","volume":"76","author":"Van Scheyen","year":"1973","journal-title":"Psychiatr. Neurol. Neurochir."},{"key":"10.1016\/j.jad.2018.10.357_bib0077","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2018.10.357_bib0078","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2174\/156802605774297092","article-title":"Is there a placebo problem in antidepressant trials?","volume":"5","author":"Yang","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jad.2018.10.357_bib0079","first-page":"638","article-title":"Tolerance to amoxapine antidepressant effects","volume":"5","author":"Zetin","year":"1982","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2018.10.357_bib0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4088\/JCP.v68n0814","article-title":"How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low","volume":"68","author":"Zimmerman","year":"2007","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718316859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718316859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:20:56Z","timestamp":1759022456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718316859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":80,"alternative-id":["S0165032718316859"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2018.10.357","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tachyphylaxis in major depressive disorder: A review of the current state of research","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2018.10.357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}